Key facts
- This page summarizes Premier Macy Management Holdings, LLC's Form 4 filing for Nutex Health, Inc. (NUTX).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 14 Dec 2022, 14:36.
Premier Macy Management Holdings, LLC - 12 Dec 2022 Form 4 Insider Report for Nutex Health, Inc. (NUTX)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- NUTX
- Reported as of
- 12 Dec 2022
- Net transaction value
- -$367,333
- SEC form
- 4
- Accepted by SEC
- 14 Dec 2022, 14:36:19 UTC
- Prior SEC filing
- 05 Apr 2022
- Source filing
- View source filing
- Reporting owner signature
- Matthew Stephen Young, Managing Member
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Premier Macy Management Holdings, LLC filed Form 4 for Nutex Health, Inc. (NUTX) on 14 Dec 2022.
Change
- Previous filing in this sequence was filed on 05 Apr 2022.
- Current net transaction value: -$367,333.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
NUTX
transaction
Class A Common Stock
Sale
- Transaction value
- $276,773
- Shares
- -125,498
- Change %
- -0.3%
- Price
- $2.21*
- Shares after
- 42,008,712
- Date
- 12 Dec 2022
- Ownership
- Direct
- Footnotes
- F1, F2, F3
NUTX
transaction
Class A Common Stock
Sale
- Transaction value
- $90,560
- Shares
- -43,880
- Change %
- -0.1%
- Price
- $2.06*
- Shares after
- 41,964,832
- Date
- 13 Dec 2022
- Ownership
- Direct
- Footnotes
- F1, F3, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
These shares were sold pursuant to a Rule 10b5-1 trading plan entered into by Premier Macy Management Holdings, LLC ("Premier").
Footnote F2
The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $2.04 to $2.445, inclusive. The reporting person undertakes to provide to Nutex Health, Inc., any security holder of Nutex Health, Inc., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 1.
Footnote F3
Premier is the direct beneficial owner of the securities reported herein. Matthew Stephen Young is the managing member of Premier and a director of Nutex Health, Inc. Mr. Young disclaims beneficial ownership of any securities that exceed his pecuniary interest in Premier.
Footnote F4
The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $2.04 to $2.12, inclusive. The reporting person undertakes to provide to Nutex Health, Inc., any security holder of Nutex Health, Inc., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 2.